CARGO Therapeutics Announces Pricing of Initial Public Offering
November 09, 2023 20:07 ET | Cargo Therapeutics, Inc.
CARGO Therapeutics Announce Pricing of IPO
BioTech Breakthrough Awards Badge[1] copy.jpg
K36 Therapeutics Named “Overall BioPharma Startup of the Year” By BioTech Breakthrough
November 08, 2023 08:05 ET | BioTech Breakthrough
CAMBRIDGE, Mass., Nov. 08, 2023 (GLOBE NEWSWIRE) -- K36 Therapeutics (“K36”) has been selected as “Overall BioPharma Startup of the Year” in the third annual BioTech Breakthrough Awards Program...
BioTech Breakthrough Awards Badge[1] copy.jpg
Garuda Therapeutics Named “Overall Cell Biology Company of the Year” By BioTech Breakthrough
November 08, 2023 08:03 ET | BioTech Breakthrough
LOS ANGELES, Nov. 08, 2023 (GLOBE NEWSWIRE) -- BioTech Breakthrough, a leading independent market intelligence organization that evaluates and recognizes standout life sciences and biotechnology...
BioTech Breakthrough Awards Badge[1] copy.jpg
BioTechnology Innovators Honored in 3rd Annual BioTech Breakthrough Awards Program
November 08, 2023 08:00 ET | BioTech Breakthrough
LOS ANGELES, Nov. 08, 2023 (GLOBE NEWSWIRE) -- BioTech Breakthrough, a leading independent market intelligence organization that evaluates and recognizes standout life sciences and biotechnology...
Michelle Shuffett
RS BioTherapeutics Promotes Michelle L. Shuffett, MD to Chief Medical Officer
October 31, 2023 11:00 ET | RS BioTherapeutics
RS BioTherapeutics is pleased to announce that it has appointed Michelle L. Shuffett, MD as its Chief Medical Officer.
website-logo (2).png
Pruritus Therapeutics Market to Reach USD 12.6 Billion by 2032, Poised for Steady 4.1% CAGR 
October 17, 2023 07:15 ET | MarketResearch.biz
New York, Oct. 17, 2023 (GLOBE NEWSWIRE) -- According to marketresearch.biz, the estimated size of the global pruritus therapeutics market in 2022 was USD 8.5 billion, and it is expected to exhibit...
Logo.jpg
ProPhase Labs to Present at The ThinkEquity Conference
October 12, 2023 08:00 ET | ProPhase Labs, Inc.
GARDEN CITY, NY, Oct. 12, 2023 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a next generation biotech, genomics, therapeutics and diagnostics company, today announced it will be...
Biodexa Completes Recruitment of Cohort A in Study of MTX110 in Patients with Recurrent Glioblastoma
October 03, 2023 08:30 ET | Biodexa Pharmaceuticals PLC
Biodexa Pharmaceuticals PLC(“Biodexa” or the “Company”) Biodexa Completes Recruitment of Cohort A in Study of MTX110 in Patients with Recurrent Glioblastoma Biodexa Pharmaceuticals PLC, (Nasdaq:...
gallanttherapeutics-bw (3).png
Ethos Discovery and Gallant Therapeutics Collaborate on Study Evaluating Gallant’s Stem Cell Therapy in Pugs with Necrotizing Meningoencephalitis (NME), also referred to as Pug Dog Encephalitis (PDE)
October 03, 2023 08:12 ET | Gallant Therapeutics
Gallant Therapeutics and Ethos Discovery collaborate in a clinical study evaluating the use of stem cells to treat pugs with early-stage NME
Research Nester Logo.jpg
Albumin Market revenue to cross USD 10 Billion by 2035, says Research Nester
October 02, 2023 06:30 ET | Research Nester
New York, Oct. 02, 2023 (GLOBE NEWSWIRE) -- The global albumin market size is slated to expand at ~ 6% CAGR between 2023 and 2035. The market is poised to garner a revenue of USD 10 Billion by the...